Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Safety and Efficacy of Ifetroban for the Treatment of Portal Hypertension in Cirrhotic Patients
Conditions
Interventions
Ifetroban
Placebo
Locations
6
United States
Tampa General Medical Group
Tampa, Florida, United States
Indiana University
Indianapolis, Indiana, United States
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Baylor University Medical Center
Dallas, Texas, United States
Virginia Commonwealth University Medical Center
Richmond, Virginia, United States
Start Date
March 6, 2017
Primary Completion Date
July 17, 2018
Completion Date
July 17, 2018
Last Updated
January 19, 2022
NCT07439939
NCT02417740
NCT06680583
NCT07437755
NCT06169592
NCT06669806
Lead Sponsor
Cumberland Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions